Advanced search
Publication Cover
European Journal of General Practice Volume 28, 2022 - Issue 1
Submit an article Journal homepage
6,894
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Chronic hepatitis C: Diagnosis and treatment made easy

Naim Abu-Frehaa The Institute of Gastroenterology and Hepatology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4844-3308
ORCID Icon,
Binil Mathew Jacobb Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel
,
Ali Elhoashlac Clalit Health Services, Beer-Sheva, Israel
,
Zaid Afawic Clalit Health Services, Beer-Sheva, Israel;d Erasmus MC, Rotterdam, The Netherlands
,
Talab Abu-Hammadc Clalit Health Services, Beer-Sheva, Israel
,
Foad Elsanac Clalit Health Services, Beer-Sheva, Israel
,
Sergey Pazc Clalit Health Services, Beer-Sheva, Israel
&
Ohad Etziona The Institute of Gastroenterology and Hepatology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
 show all
Pages 102-108 | Received 30 Oct 2021, Accepted 03 Mar 2022, Published online: 17 May 2022

References

  • The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–176.
  • European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European union by 2030: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(5):325–336.
  • Isakov V, Tsyrkunov V, Nikityuk D. Is elimination of hepatitis C virus realistic by 2030: Eastern Europe. Liver Int. 2021;41(S1):50–55.
  • Petruzziello A, Marigliano S, Loquercio G, et al. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infect Agent Cancer. 2016; 12:11–53.
  • Su J, Brook RA, Kleinman NL, et al. The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Hepatology. 2010;52(2):436–442.
  • Guidelines for the screening, care and treatment of persons with hepatitisC infection. Geneva, Switzerland: World Health Organization; 2017. [cited 2021 Aug 28]. Available from: https://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf
  • Ferraro M, and Painter M, Hepatitis C. Screening, diagnosis, management & treatment. Osteopath Fam Physician. 2019;11(1):12–19.
  • Carrat F, Fontaine H, Dorival C, French ANRS CO22 Hepather cohort, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019;393(10179):1453–1464.
  • Van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. J Am Med Assoc. 2012;308(24):2584–2593.
  • Nahon P, Bourcier V, Layese R, et al. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications. Gastroenterology. 2017;152(1):142–156.
  • Kanwal F, Kramer J, Asch SM, et al. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153(4):996–1005.
  • Ioannou GN, Green PK, Beste LA, et al. Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. J Hepatol. 2018;69(5):1088–1098.
  • Calvaruso V, Cabibbo G, Cacciola I, et al. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology. 2018;155(2):411–421.
  • Li DK, Ren Y, Fierer DS, et al. The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: an ERCHIVES study. Hepatology. 2018;67(6):2244–2253.
  • Kanwal F, Kramer JR, Asch SM, et al. Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents. Hepatology. 2020;71(1):44–55.
  • Harris RJ, Ramsay M, Hope VD, et al. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. Eur J Public Health. 2012;22(2):187–192.,
  • Mann AG, Trotter CL, Balogun MA, et al. Hepatitis C in ethnic minority populations in England. J Viral Hepat. 2008;15(6):421–426.
  • EASL recommendations on treatment of hepatitis C final update of the series. J. Hep. 2020;73(5):1170–1218.
  • Ghany MG, Morgan TR, AASLD‐IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American association for the study of liver diseases–infectious diseases society of america recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686–721.
  • Vázquez-Morón S, Ardizone Jiménez B, Jiménez-Sousa M, et al. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: a systematic review and meta-analysis. Sci Rep. 2019;9(1):7316.
  • Poiteau L, Soulier A, Rosa I, et al. Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots. J Viral Hepat. 2016;23(5):399–401. 401.
  • Sterling R, Lissen E, Clumeck N, APRICOT Clinical Investigators, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
  • Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598–607.
  • World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. [cited 2021 Aug 31]. Available from: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=60A93ADD1A191FF6A0FA823314D24C43?sequence=1. (WHO, 2016).
  • Ballestín S, Gómez Martín D, Lorente Pérez S, et al. Hepatitis C: a pharmacological therapeutic update. J Clin Med. 2021;10(8):1568.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.